Pentamidine isothionate treatment for New World mucocutaneous Leishmaniasis;Traitement par isethionate de pentamidine de la Leishmaniose muqueuse

Annales de Dermatologie et de Venereologie

Volumn 125, Issue 8, 1998, Pages 492-495

  Amato, V ^a   Amato, J ^a   Nicodemo, A ^a   Uip, D ^a   Amato Neto, V ^a   Duarte, M ^b  

^a Dept Maladies Infectieuses P ^*  (Brazil)

^b Lab Pathol Maladies Infectieuses

Author keywords

[No Author keywords available]

Indexed keywords

PENTAMIDINE ISETHIONATE; ANTIPROTOZOAL AGENT; PENTAMIDINE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FRANCE; HUMAN; LEISHMANIA BRAZILIENSIS; RELAPSE; SKIN LEISHMANIASIS; ADULT; AGED; ANIMAL; DOSE RESPONSE; DRUG ADMINISTRATION; FEMALE; FOLLOW UP; MALE; MIDDLE AGED;

ADULT; AGED; ANIMALS; ANTIPROTOZOAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; MIDDLE AGED; PENTAMIDINE;

EID: 0031876505     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendric Keds. The Leishmanioses in Biology and Medicine. London: Academic Press 1987:1-120.
2. Franke ED, Wignall S, Cruz ME, Rosales E, Tovar AA, Lucas CM, Llanos-Cuentas A. Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis. Ann Intern Med 1990;113:934-40.
3. Marsden PD. Mucosal leishmaniasis (≪ espundia ≫ Escomel, 1911). Trans R Soc Trop Med Hyg 1986;80:859-76.
4. Amato VS, Boulos MIC, Amato Neto V. Filomeno LTB Utilizaçào do tubo em ≪ T ≫de silicone para tratamento de um caso de leishmaniose tegumentar americana com traqueomalácia. Rev Soc Bras Med Trop 1995;28:129-30.
5. Marsden PD. Pentavalent antimonials: old drugs for new diseases. Rev Soc Bras Med Trop 1985;18:187-98.
6. Oliveira MRF, Macêdo VO. Carvalho M, Barral A, Marotti JG, Bittencourt A et al. Estudo evolutivo da leishmaniose mucosa (7 a 17 anos se seguimento) causada por Leishmania (Viannia) braziliensis cm trés de braços, Bahia Rev Soc Bras Med Trop 1995;28:325-32.
7. Sands M, Kron MA, Brown RB. Pentamidine: a review. Rev Infect Dis 1985;7:625-34.
8. Pradinaud R, Servans G, Saint-Marie D, Girardeau I, Gotz W, Will F. Bilan de 10 années de traitement de la leishmaniose tégumentaire par la pentamidine en Guyane Française: à propos de 1 025 cas. Nouv Dermatol 1991;10:456-61.
9. WHO Expert committee. The Leishmaniasies. WHO Tech Report Ser 1984;701:99-109.
10. Robert AG Jr, Magill AJ, Oster CN, Franke ED, Grögl M, Berman JD. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 1994;18:83-90.
11. Berman JD Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future Strategies. Rev Infect Dis 1984;10:560-85.
12. Thakur CP. Epidemiological, clinical and therapeutic features of Binar kala-azar. Trans R Soc Trop Med Hyg 1984;78:391-8.
13. Pradinaud R. Le traitement de la leishmaniose tegumentaire par la pentamidine en Guyane Française. Med Trop 1994;54:418-22.
14. Croft SL, Brazil RP. Effect of pentamidine isethionate on the ultrastructure and morphology of Leishmania mexicana amazonensis ≪ in vitro ≫. Ann Trop Med Parasitol 1982;76:37-43.
15. Western KA, Perera DR, Schultz MG. Pentamidine isethionate in the treatment of Pneumocystis carinni pneumoniae. Ann Intern Med 1970;73:695-702.
16. Sampaio RNR, Snares SKP, Rosa AC, Martins Netto E, Magalhāes AV, Marsden PD. Tratamento com pentamidina de seis casos da forma mucosa de leishmaniose tegumentar. An Bras Dermatol 1988;63:439-42.
17. Amato VS, de Paula JJ, Imamura R, Amato Neto V, Duarte MI, Boulos MI et al. Tratamento da leishmaniose tegumentar americana. coin lesào em mucosa, por meio do isotionato de pentamidina. Rev Soc Bras Med Trop 1996;29:477-81.
18. Sampaio SAP, Godoy JT, Paiva L, Dillon NL, Lacaz CS. The treatment of american (mucocutaneous) leishmaniasis with amphotericin B. Arch Dermatol 1960;82:195-203.
19. Sampaio RNS. Marsden PD Mucosal leishmaniasis unresponsive to glucantime therary successfully treated with Ambissome. Trans R Soc Trop Med Hyg 1997;91:77.
20. Ureuyo FG, Zaias N. Oral ketoconazole in the treatment of leishmaniasis. Int J Dermatol 1982:21:414-6.
21. Falcoff E, Taranto NJ, Remondegui CE, Dedet JP, Canini LM, Ripoll CM et al. Clinical healing of antimony-resistent cutaneous or mucocutaneous leishmaniasis following the combined administration of interferon-γ and pentavalent antimonial compounds. Trans R Soc Trop Med Hvg 1994;88:95-7.